Table 3. Person-reported outcome measures assessing treatment expectations, trust, and satisfaction.

Questionnaire	FCL treatment period	Control period	p-value
DTSQs, Diabetes Treatment Satisfaction Questionnaire status; INSPIRE, Insulin Delivery Systems: Perceptions, Ideas, Reflections and Expectations; TAS, Technology Acceptance Scale. Data are expressed as the median (IQR). Sample sizes: Parents (n = 11); adolescents (n = 13).
DTSQs: Parents	40.5 (38.0–45.0)	35.0 (28.5–39.0)	0.083
Perceived diabetes control	9.0 (6.3–10.0)	5.0 (3.5–6.0)	0.028
Perceived hypoglycemia	2.0 (1.3–2.8)	3.0 (2.0–4.0)	0.028
Perceived hyperglycemia	2.0 (1.3–4.8)	5.0 (4.0–5.0)	0.047
DTSQs: Adolescents	38.0 (35.0–44.0)	35.0 (27.0–39.0)	0.042
Perceived diabetes control	9.0 (6.0–10.0)	5.0 (4.0–8.0)	0.077
Perceived hypoglycemia	1.0 (1.0–2.0)	3.0 (2.0–3.0)	0.027
Perceived hyperglycemia	2.0 (1.0–4.0)	4.0 (3.0–5.0)	0.054
INSPIRE: Parents	81.0 (69.0–87.0)	72.0 (65.5–6.5)	0.157
INSPIRE: Adolescents	73.0 (69.0–75.0)	75.0 (66.0–82.0)	0.339
TAS: Parents	21.5 (20.0–23.0)	19.0 (17.0–21.0)	0.005
TAS: Adolescents	22.0 (19.0–23.0)	20.0 (19.0–21.0)	0.893